scholarly article | Q13442814 |
P2093 | author name string | Gang Ren | |
Jian-Dong Jiang | |||
Wei-Jia Kong | |||
Jiang-Hong Guo | |||
Yu-Zhen Qian | |||
P2860 | cites work | Gastrodin Protects against Ethanol-Induced Liver Injury and Apoptosis in HepG2 Cells and Animal Models of Alcoholic Liver Disease | Q54224802 |
Hexane-Isopropanolic Extract of Tungrymbai, a North-East Indian fermented soybean food prevents hepatic steatosis via regulating AMPK-mediated SREBP/FAS/ACC/HMGCR and PPARα/CPT1A/UCP2 pathways. | Q55642037 | ||
Berberine activates thermogenesis in white and brown adipose tissue | Q86052055 | ||
Learning from berberine: Treating chronic diseases through multiple targets | Q38156718 | ||
Current knowledge and pharmacological profile of berberine: An update | Q38532800 | ||
Berberine acutely activates the glucose transport activity of GLUT1 | Q39547455 | ||
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. | Q40218653 | ||
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states | Q40250572 | ||
Berberine activates AMPK to suppress proteolytic processing, nuclear translocation and target DNA binding of SREBP-1c in 3T3-L1 adipocytes | Q42258667 | ||
The Compound of Mangiferin-Berberine Salt Has Potent Activities in Modulating Lipid and Glucose Metabolisms in HepG2 Cells | Q42492483 | ||
Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes | Q42521110 | ||
Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action | Q46745033 | ||
Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux | Q46797385 | ||
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3 spatially mediates autophagy through the AMPK signaling pathway | Q47094365 | ||
TGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis | Q48364918 | ||
Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice. | Q50220203 | ||
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia | Q24290495 | ||
Berberine improves glucose metabolism through induction of glycolysis | Q24642953 | ||
Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy | Q26798253 | ||
Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease | Q27301440 | ||
Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis | Q28477076 | ||
Berberine promotes glucose consumption independently of AMP-activated protein kinase activation | Q28541332 | ||
Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity | Q34603754 | ||
Tissue distribution of berberine and its metabolites after oral administration in rats | Q35035856 | ||
Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway | Q36216779 | ||
Metformin Regulates Glucose Transporter 4 (GLUT4) Translocation through AMP-activated Protein Kinase (AMPK)-mediated Cbl/CAP Signaling in 3T3-L1 Preadipocyte Cells | Q36492756 | ||
Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis | Q37227111 | ||
AMPK in Health and Disease | Q37543855 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 647 | |
P577 | publication date | 2020-05-08 | |
P1433 | published in | Frontiers in Pharmacology | Q2681208 |
P1476 | title | Berberine Improves Glucose and Lipid Metabolism in HepG2 Cells Through AMPKα1 Activation | |
P478 | volume | 11 |